Texas Attorney General Ken Paxton is suing the makers of Tylenol, claiming the companies hid alleged dangers that the drug posed to children's brain development. This lawsuit comes a month after President Donald Trump promoted an unproven link between taking Tylenol - also known as paracetamol - during pregnancy and autism in children.
Paxton is suing Johnson & Johnson, which previously sold the drug, the only pain reliever recommended for pregnant women, and Kenvue, which now manufacturers it. In a statement, he said they betrayed America by profiting off of pain and pushing pills regardless of the risks. Kenvue, however, contests these claims, asserting that there is no credible evidence linking Tylenol to autism.
These corporations lied for decades, knowingly endangering millions to line their pockets, Paxton, a Republican, stated. Kenvue expressed concerns over the misinformation regarding the safety of acetaminophen, emphasizing their commitment to continuous science evaluation.
The American College of Obstetricians and Gynecologists has indicated that acetaminophen is among the few safe options for pain and fever treatment in pregnant women, adding that extensive research has found no reputable studies linking acetaminophen in pregnancy with neurodevelopmental disorders.
The lawsuit points to President Trump's recent statements as part of its basis for claiming that the drug is allegedly unsafe. Trump's remarks alarmed public health officials and led to a notice from the U.S. Food and Drug Administration (FDA) suggesting that doctors consider limiting Tylenol use, although they specified that no causal relationship between the drug and autism has been established.
Past lawsuits by parents alleging links between Tylenol and autism have been dismissed, reflecting the challenges in asserting scientific conclusions regarding such complex issues. Paxton's legal action seeks to compel the companies to halt any marketing that claims Tylenol is safe for pregnant women.
Paxton is suing Johnson & Johnson, which previously sold the drug, the only pain reliever recommended for pregnant women, and Kenvue, which now manufacturers it. In a statement, he said they betrayed America by profiting off of pain and pushing pills regardless of the risks. Kenvue, however, contests these claims, asserting that there is no credible evidence linking Tylenol to autism.
These corporations lied for decades, knowingly endangering millions to line their pockets, Paxton, a Republican, stated. Kenvue expressed concerns over the misinformation regarding the safety of acetaminophen, emphasizing their commitment to continuous science evaluation.
The American College of Obstetricians and Gynecologists has indicated that acetaminophen is among the few safe options for pain and fever treatment in pregnant women, adding that extensive research has found no reputable studies linking acetaminophen in pregnancy with neurodevelopmental disorders.
The lawsuit points to President Trump's recent statements as part of its basis for claiming that the drug is allegedly unsafe. Trump's remarks alarmed public health officials and led to a notice from the U.S. Food and Drug Administration (FDA) suggesting that doctors consider limiting Tylenol use, although they specified that no causal relationship between the drug and autism has been established.
Past lawsuits by parents alleging links between Tylenol and autism have been dismissed, reflecting the challenges in asserting scientific conclusions regarding such complex issues. Paxton's legal action seeks to compel the companies to halt any marketing that claims Tylenol is safe for pregnant women.
